Short communication · 2017
ArticlePublished 2011
Vancomycin MIC trend and association with outcomes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Over the past decade, an increasing trend in vancomycin minimum inhibitory concentration (MIC) levels for methicillin resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus has been reported. The phenomenon has been a topic of great interest in light of limited new and novel antimicrobial therapy in recent years. The goals of this study were to examine the relationship between high vs. low vancomycin MIC and patient outcomes, to assess the usage of vancomycin over time, and to determine whether an increase in vancomycin MIC had occurred among MRSA clinical isolates over time.Methods and Findings: A retrospective study was conducted from January 1, 1998 through December 31, 2008. Using the electronic medical record database, patients with blood, wound, or intravenous catheter tip cultures positive for MRSA during the study period were identified and reviewed. Variables abstracted from the electronic medical record for these patients included age, sex, site of culture, vancomycin MIC value, duration of vancomycin therapy, additional antibiotics prescribed,and co-morbidities including diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), malignancy, and liver disease. The DDD/100 days was calculated for the years 2002 through 2009. Two hundred andforty one (n=241) MRSA cultures were identified and used in the study. We identified a statistically significant upward trend in high vs. low vancomycin MICs from 1998 to 2008 (p<0.001). Past medical history of diabetes (RR=0.77, 95% CI, 0.57 to 1.02) was associated with Low vancomycin MIC compared to a high MIC, but did not reach statistical significance (p=0.07). History of liver disease (RR=0.40; 95% CI, 0.17 to 0.96)was associated with low MIC compared to a high MIC but did not reach statistical significance (P= 0.083). There was no statistically significant association between high and low MIC and 30 day mortality (p=0.21). There was a significant difference in mean vancomycin duration between those who died and those who survived (P= 0.0001), 8 vs. 18 days respectively. There was no statistically significant association between length of stay and high and low MIC (p=0.5). There was an increasing trend in vancomycin DDD/100 days from 2002 through 2009. Limitations of this study include the retrospective design and the almost exclusive male population (97%, 233/241).Conclusions: A significant upward trend in vancomycin MIC values over an 11-year period was identified at our institution. This trend was not associated with increased 30-day mortality or increased length of stay. An overall increase in the use of vancomycin (DDD/100 days) over the last eight years of the study period was also noted (range 2.4 to 4.3), suggesting a possible driving force for the increase in MIC. Larger,prospective, randomized studies would be order soma helpful in substantiating these findings.
Subjects
MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Jun 2015
Temporal Trends in Clinical Characteristics and 12-months Outcome of Patient’s enrolled in ART program during 2004 to 2012 in Dar es Salaam, Tanzania
Conference abstract · 18 Sep 2020
Trends of Post-vaccination Rotavirus infection and its association with other viruses
Research article · 11 Dec 2016
Association of IGF-1 gene polymorphism with milk production traits and paternal genetic trends in Iranian Holstein bulls
Conference abstract · 28 Nov 2016
Trends in HIV associated TB in Benin City, Nigeria
More from this journal
The newest in Archives of Clinical Microbiology.
Short communication · 24 Dec 2024
Hepatitis Virus: Understanding the Types, Symptoms and Prevention
Short communication · 24 Dec 2024
Exploring the Frontiers of Microbial Genomics: Unravelling the Secrets of Microbial Diversity
Short communication · 24 Dec 2024
Staphylococcus aureus: A Microbial Mastermind
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Clinical Microbiology
- SubjectMicrobiology
- BylineArticles whose byline prints “Katie A Kincaid”
- BylineArticles whose byline prints “Stephen Syverson”
- BylineArticles whose byline prints “Stephanie Borchardt”
- BylineArticles whose byline prints “Ji M Koo”
- BylineArticles whose byline prints “Tze Shien Lo”

